ALEXANDER PUSHKA: Open Payments
NPI 1992793384 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,059 in 91 payments from 12 companies in 2025. Trend: 2023 $1,270 · 2024 $1,333 · 2025 $2,059
Food & beverage: $2,059
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $419 |
| Neurocrine BioSciences, Inc. | 11 | $351 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $349 |
| Teva Pharmaceuticals USA, Inc. | 12 | $251 |
| Almatica Pharma LLC | 9 | $205 |
| Janssen Pharmaceuticals, Inc | 10 | $183 |
| Axsome Therapeutics, Inc. | 7 | $156 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: ARISTADA, INGREZZA, CAPLYTA, LOREEV XR, AUSTEDO XR, Auvelity, SPRAVATO, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
